Recent Advances and Mechanism of Nanomaterials Promoting Tumor Metastasis

Weiyi Wang1, Xinlong Pang1, Mengzhen Dong1

  • 1School of Chemistry and Pharmaceutical Engineering, Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250000, China.

Insights

Certain nanomaterials can unexpectedly promote tumor metastasis by affecting tumor cells, blood vessels, and inflammation. Understanding these mechanisms is key to developing safer nanotechnology for cancer treatment.

Area of Science:

  • Nanomedicine
  • Cancer Biology
  • Materials Science

Background:

  • Tumor metastasis is a critical challenge in malignant tumor treatment.
  • Nanotechnology offers novel strategies for cancer therapy.
  • Previous research focused on nanomaterials to inhibit tumors and metastasis.

Purpose of the Study:

  • To review and summarize the mechanisms by which some nanomaterials promote tumor metastasis.
  • To highlight the role of nanomaterials in cancer progression.

Main Methods:

  • Comprehensive literature review of recent research on nanomaterials and tumor metastasis.
  • Analysis of studies detailing the molecular and cellular mechanisms involved.

Main Results:

  • Nanomaterials can induce epithelial-mesenchymal transition (EMT) in tumor cells.
  • Nanomaterials interact with the tumor vasculature, potentially aiding metastasis.
  • Nanomaterials can induce inflammation, contributing to tumor spread.

Conclusions:

  • Understanding how nanomaterials promote metastasis is crucial.
  • This knowledge will guide the development of safer, more effective nanomedicines.
  • Future nanotechnologies can be designed to minimize metastasis promotion.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K